Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study

Diabetologia
T M E DavisD G Bruce

Abstract

The aim of this study was to assess the relationships between lipid-lowering therapy and the prevalence and incidence of peripheral sensory neuropathy in type 2 diabetes mellitus. We analysed data from an observational cohort study, the Fremantle Diabetes Study (FDS), specifically, (1) a cross-sectional sample comprising 1,237 FDS participants with type 2 diabetes mellitus, and (2) a longitudinal subgroup of 531 individuals who had attended six consecutive annual assessments. Neuropathy was identified using the clinical portion of the Michigan Neuropathy Screening Instrument. At entry, the cross-sectional sample had a mean +/- SD age of 63.8+/-11.3 years, 48.7% were men, median (interquartile range) diabetes duration was 4.0 (1.0-9.0) years, and 30.9% had peripheral neuropathy. Fibrates and statins were used by 3.5 and 6.8%, respectively. Multiple logistic regression analysis showed that older age, longer diabetes duration, central adiposity, increased height, higher fasting serum glucose, albuminuria and aboriginality were significant independent positive predictors of prevalent neuropathy, while systolic blood pressure and fibrate use (odds ratio 0.30, 95% CI 0.10-0.86; p=0.025) were negatively associated. In the longitudinal...Continue Reading

References

Jan 1, 1968·Transactions of the American Clinical and Climatological Association·G G DuncanJ Schatanoff
Jun 22, 2000·The New England Journal of Medicine·K Benson, A J Hartz
Oct 29, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·T M DavisI R Mackay
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Nov 18, 2004·Journal of Epidemiology and Community Health·Giovanni CorraoPaolo Contiero
Sep 10, 2005·Clinical Neurology and Neurosurgery·Ali MoghtaderiHomayra Rashidi
Oct 18, 2005·Biochemical Pharmacology·Ganesaratnam K Balendiran, Balakrishnan Rajkumar
Nov 1, 2006·International Journal of Clinical Practice·A GirachM Porta

❮ Previous
Next ❯

Citations

Dec 4, 2009·Current Diabetes Reports·Solomon Tesfaye, Dinesh Selvarajah
May 17, 2013·Current Diabetes Reports·Vincenza Spallone, Carla Greco
May 18, 2013·Current Diabetes Reports·Aaron I VinikHenri Parson
Dec 17, 2008·Current Neurology and Neuroscience Reports·Louis H Weimer, Noor Sachdev
Dec 8, 2011·Current Neurology and Neuroscience Reports·Mengjing Chloe Huan, Mark Bromberg
Jul 4, 2012·Indian Journal of Clinical Biochemistry : IJCB·Michael B AdinorteyAlexander K Nyarko
May 1, 2012·International Journal of Epidemiology·Timothy M E DavisWendy A Davis
Jun 17, 2011·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Gillian M Keating
Sep 29, 2011·Drugs·Kate McKeage, Gillian M Keating
May 5, 2009·Diabetes·Timothy D WigginEva L Feldman
Aug 3, 2014·The Journal of Pain : Official Journal of the American Pain Society·Shrutya BhallaAmteshwar Singh Jaggi
Aug 30, 2014·Expert Opinion on Investigational Drugs·Ernest AdeghateHuba Kalász
Aug 28, 2010·Expert Opinion on Emerging Drugs·Abd A TahraniMartin J Stevens
Aug 28, 2015·Journal of the Peripheral Nervous System : JPNS·Michael PolydefkisUNKNOWN Ranirestat Study Group
Dec 4, 2010·Diabetes & Metabolism·P Valensi, S Picard
Aug 17, 2010·Journal of Diabetes and Its Complications·Christina VoulgariNicholas Tentolouris
May 4, 2010·Medicina clínica·Jesús Millán Núñez-CortésUNKNOWN Iniciativa para la Reducción del Riesgo Residual
Feb 23, 2010·Primary Care Diabetes·Niina MatikainenMarja-Riitta Taskinen
Nov 4, 2015·Journal of Diabetes and Its Complications·Phillipe D O'BrienEva L Feldman
Dec 3, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·P MyhillT M E Davis
Mar 1, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·R A MalikD Ziegler
Dec 22, 2009·Journal of the Peripheral Nervous System : JPNS·Andrea M VincentEva L Feldman
Dec 17, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Z Argov
Aug 21, 2015·Oxidative Medicine and Cellular Longevity·Geannyne Villegas-RiveraAlejandra Guillermina Miranda-Díaz
Nov 11, 2014·Expert Opinion on Pharmacotherapy·Nikolaos Papanas, Dan Ziegler
Nov 14, 2013·Somatosensory & Motor Research·Brenton WestTerry P Haines
Dec 20, 2008·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Runhua HouGarry Stuart Tobin
Apr 16, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Yehuda HandelsmanUNKNOWN AACE Task Force for Developing Diabetes Comprehensive Care Plan
Apr 15, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Yehuda HandelsmanFarhad Zangeneh
Mar 17, 2015·Current Diabetes Reports·Rafael SimóCristina Hernández
May 6, 2016·Naunyn-Schmiedeberg's Archives of Pharmacology·Onkar BediPuneet Kumar
Apr 4, 2017·British Journal of Clinical Pharmacology·Toke de Koning SvendsenDavid Gaist
Feb 14, 2017·Journal of Diabetes Research·M C Perez-MatosC O Mendivil
Oct 30, 2008·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Jean-Charles FruchartUNKNOWN Residual Risk Reduction Initiative (R3I)
Jun 22, 2011·Kidney & Blood Pressure Research·Christoph Wanner, Vera Krane
Jul 11, 2018·Diabetes Care·Signe T AndersenMorten Charles

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.